Apyx Medical Corporation Stock
Equities
APYX
US03837C1062
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | -9.64% | +6.38% | -42.75% |
May. 09 | Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical | CI |
Financials (USD)
Sales 2024 * | 50.01M | Sales 2025 * | 54.67M | Capitalization | 51.97M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -24M | EV / Sales 2024 * | 1.04 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.95 x |
P/E ratio 2024 * |
-2
x | P/E ratio 2025 * |
-2.21
x | Employees | 252 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.08% |
Latest transcript on Apyx Medical Corporation
1 day | -9.64% | ||
1 week | +6.38% | ||
Current month | +4.90% | ||
1 month | -3.23% | ||
3 months | -40.48% | ||
6 months | -14.53% | ||
Current year | -42.75% |
Managers | Title | Age | Since |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 17-12-14 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | Dec. 03 |
Kari Larson
CTO | Chief Tech/Sci/R&D Officer | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Waldman
BRD | Director/Board Member | 77 | 11-03-14 |
Craig Swandal
BRD | Director/Board Member | 63 | 18-03-08 |
John Andres
BRD | Director/Board Member | 66 | 14-07-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.5 | -9.64% | 262,894 |
24-05-09 | 1.66 | +22.96% | 283,370 |
24-05-08 | 1.35 | -4.26% | 35,769 |
24-05-07 | 1.41 | +0.71% | 49,553 |
24-05-06 | 1.4 | -0.71% | 28,646 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.75% | 51.97M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
+13.67% | 25.02B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- APYX Stock